logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
T

Tomás Pascual

Harvard University
H指数:35
被引数:5,499

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Neoadjuvant palbociclib and endocrine therapy versus chemotherapy in ER + /HER2- breast cancer: a randomized phase II trial

新辅助palbociclib联合内分泌治疗与化疗在ER+/HER2-乳腺癌中的比较：一项随机II期试验

Nature Communications
IF15.7
2026-04-080
OAAI
Alexios Matikas; Evangelos Tzoras; Michail Sarafidis; Emmanouil G. Sifakis; Judith Bjöhle; Elin Barnekow; Sara Margolin; Erika Isaksson-Friman; Luisa Edman Kessler; Athanasios Zouzos; Hemming Johansson; Mats Hellström; Susanne Agartz; Per Grybäck; Dimitrios Salgkamis; Ioannis Zerdes; Kang Wang; Johan Hartman; Balazs Acs; Wenwen Sun; Ceren Boyaci; Guillermo Villacampa; Tomas Pascual; Joaquin Gavila; Aleix Prat; Charles Perou; Yvonne Brandberg; Jonas Bergh; Thomas Hatschek; Theodoros Foukakis
Talimogene laherparepvec and atezolizumab in HER2-negative breast cancer following neoadjuvant chemotherapy: a window-of-opportunity phase II trial (SOLTI-1503 PROMETEO)

talimogene laherparepvec和atezolizumab在HER2阴性乳腺癌新辅助化疗后的应用：一项窗口期II期试验（SOLTI-1503 PROMETEO）

Nature Communications
IF15.7
2026-02-160
OA
Tomás Pascual; Maria Vidal; Juan M. Cejalvo; Estela Vega; Esther Sanfeliu; Guillermo Villacampa; Sergi Ganau; Ana María Julve Parreño; Esther Zamora; Ignacio Miranda; Ana Delgado; Begoña Bermejo; Elia Seguí; Fara Brasó-Maristanty; Luis de la Cruz-Merino; Manel Juan; Patricia Galván; Xavier Gonzàlez-Farré; Samyukta Chillara; Patricia Villagrasa; Adam D. Pfefferle; Constandina E. O’Connell; Juan M. Ferrero-Cafiero; Mafalda Oliveira; Charles M. Perou; Aleix Prat
Endocrine-based strategies after CDK4/6 inhibitors in biomarker-selected subgroup of hormone receptor positive advanced breast cancer: A systematic review and network meta-analysis

内分泌为基础的策略在激素受体阳性晚期乳腺癌生物标志物选择亚组中CDK4/6抑制剂后的应用：一项系统评价和网络Meta分析

Cancer Treatment Reviews
IF10.5
2025-12-030
PRE
Alicia Escudero; Meritxell Bellet; Cristina Saura; Anna Aguilera; Andri Papakonstantinou; Pablo Tolosa; José Ángel García-Sáenz; Fernando Moreno; Alfonso López de Sá; Francesco Schettini; Elia Seguí; Marta Gonzalez-Rodriguez; Victor Navarro; Juan Manuel Ferrero-Cafiero; Xavier González; Cristina Hernando; Alexios Matikas; Aleix Prat; Mafalda Oliveira; Tomas Pascual
Ki67 dynamic predicts endocrine sensitivity in estrogen receptor-positive/HER2-negative breast cancer patients undergoing preoperative endocrine therapy

Ki67动态变化可预测接受术前内分泌治疗的雌激素受体阳性/HER2阴性乳腺癌患者的内分泌敏感性。

ESMO Open
IF8.3
2025-10-160
OAAI
R. Gómez-Bravo; B. Walbaum; M. Bergamino; O. Martínez-Sáez; F. Schettini; E. Seguí; I. García-Fructuoso; T. Pascual; N. Chic; M. González; A. Rodríguez; M. Rey; P. Giménez-Xavier; P. Blasco; O. Castillo; P. Galván; E. Sanfeliu; B. González-Farré; M. Vidal; B. Adamo; F. Brasó-Maristany; A. Prat; M. Muñoz
Comparative efficacy between real-world and randomized studies of palbociclib+endocrine therapy in HR-positive/HER2-negative metastatic breast cancer: systematic review and meta-analysis

真实世界研究与随机研究之间帕博西利布联合内分泌疗法在激素受体阳性/人表皮生长因子受体2阴性转移性乳腺癌中的比较疗效：系统评价与meta分析

JNCI CANCER SPECTRUM
IF4.1
2025-10-010
OAAI
Schettini, Francesco; Nucera, Sabrina; Di Grazia, Giuseppe; Giudici, Fabiola; Strina, Carla; Milani, Manuela; Tancredi, Richard; Conte, Benedetta; Criscitiello, Carmen; Giuliano, Mario; Lambertini, Matteo; Sanchez-Bayona, Rodrigo; Pascual, Tomas; Arpino, Grazia; Del Mastro, Lucia; Vigneri, Paolo; Cristofanilli, Massimo; Rugo, Hope S.; Gennari, Alessandra; Curigliano, Giuseppe; Generali, Daniele
Efficacy of anti-PD1 therapy in PD1-high mRNA tumors across multiple cancer types: results from cohort 1 and cohort 2 of the phase II SOLTI-1904 ACROPOLI trial

PD1疗法在PD1高表达mRNA肿瘤中的疗效：SOLTI-1904 ACROPOLI II期试验中队列1和队列2的结果

ESMO Open
IF8.3
2025-09-300
OAAI
E. Seguí; F. Brasó-Maristany; T. Pascual; E. Sanfeliu; I. Victoria; C. Saura; C. Hierro; A. López-González; Y. Izarzugaza; E. Ciruelos; J. Gavilá; F. Racca; J.M. Cejalvo; K. Amillano; L. Paz-Ares; M. Juan; E. Felip; E. Garralda; B. González; A. Arance; J. Martín-Liberal; B. Conte; B. Walbaum; A. Indacochea; O. Castillo; P. Blasco; F. Pardo; Á. Aguirre; V. Sirenko; X. González; P. Galván; A. Vivancos; J.M. Ferrero-Cafiero; A. Mulero-Sánchez; F. Salvador; G. Villacampa; R. Mesía; A. Cervantes; A. Prat; J. Tabernero
Genomic and clinical features in young women with estrogen receptor-positive, HER2-negative breast cancer

雌激素受体阳性、HER2阴性乳腺癌年轻女性的基因组与临床特征

ESMO Open
IF8.3
2025-09-240
PREAI
B. Walbaum; O. Martínez-Sáez; F. Brasó-Maristany; E. Seguí; N. Chic; J. Muñoz i Carrillo; J. Antonio Sola; M. Rey; P. Giménez-Xavier; R. Gómez-Bravo; I. García-Fructuoso; T. Pascual; A. Rodriguez-Hernandez; F. Schettini; M. Bergamino; M. González; L. Angelats; B. Adamo; M. Muñoz; E. Sanfeliu; A. Martínez-Pozo; P. Galván; P. Jares; J.A. Puig-Butillé; I. Cebrecos; C. Sánchez; A. Prat; M. Vidal
Preoperative Radiotherapy-Induced Molecular and Immune Modulation in Early-Stage Breast Cancer: Results from the YOUNGSTER Trial

术前放疗诱导的分子和免疫调控在早期乳腺癌中的作用：YOUNGSTER试验的结果

international journal of radiation oncology biology physics
IF0
2025-08-050
OA
Carles Gomà; Meritxell Mollà; Gabriela Oses; Esther Sanfeliu; Adela Rodríguez-Hernández; Blanca González-Farré; Patricia Galván; Valeria Sirenko; Oleguer Castillo; Paula Blasco; Alba Llop-Guevara; Violeta Serra; Sergi Ganau; Belén Úbeda; Xavier Bargalló; Carla Cases; Artur Latorre-Musoll; Olga Martínez-Sáez; Isabel Garcia-Fructuoso; Raquel Gómez-Bravo; Francesco Schettini; Barbara Adamo; Tomás Pascual; Maria Vidal; Montserrat Muñoz; Maria Laplana; Isaac Cebrecos; Eduard Mension; Aleix Prat; Fara Brasó-Maristany
Preoperative localization of metastatic axillary lymph nodes using radioactive iodine seed before neoadjuvant chemotherapy. A one-step marking method for targeted axillary dissection

术前放射性碘粒子标记转移性腋窝淋巴结，用于新辅助化疗前的靶向腋窝清扫。一步标记法

European Journal of Nuclear Medicine and Molecular Imaging
IF7.6
2025-07-310
PRE
Miguel Macedo; Eduard Agustí; Sergi Ganau; Belén Úbeda; Carla Sitges; Jordi Ribera-Perianes; Gabriela Oses; Tomás Pascual; Eduard Mension; Sergi Vidal-Sicart; Xavi Bargalló
HER2DX and survival outcomes in early-stage HER2-positive breast cancer: an individual patient-level meta-analysis

HER2DX和早期HER2阳性乳腺癌的生存结局：一项基于个体患者水平的荟萃分析

lancet oncology
IF0
2025-07-140
PRE
Guillermo Villacampa; Tomás Pascual; Paolo Tarantino; Javier Cortés; José Perez-García; Antonio Llombart-Cussac; Pierfranco Conte; Mario Mancino; Valentina Guarneri; Maria Vittoria Dieci; Adrienne G Waks; Francesco Schettini; Fara Brasó-Maristany; Gaia Griguolo; Beatriz Alonso de Castro; Cristina Reboredo; Silvia Antolín; Coralia Bueno-Muiño; Isabel Echavarría; Sara López-Tarruella; Tatiana Massarrah; María del Monte-Millán; Miguel Martín; Wesley Buckingham; Joel S Parker; Ana Vivancos; Kornelia Polyak; Otto Metzger Filho; Antonio C Wolff; Angela DeMichele; Nadine M Tung; Charles M Perou; Laia Paré; Patricia Villagrasa; Aleix Prat; Sara M Tolaney
HER2DX ERBB2 mRNA score in first-line advanced HER2-positive breast cancer treated with chemotherapy, trastuzumab, and pertuzumab

HER2DX ERBB2 mRNA评分：用于接受化疗、曲妥珠单抗和帕妥珠单抗治疗的一线晚期HER2阳性乳腺癌

NPJ BREAST CANCER
IF7.6
2025-04-250
OA
Sanchez-Bayona, Rodrigo; Martinez-Saez, Olga; Romero-Romero, Denys; Segui, Elia; Carcelero, Esther; Tolosa, Pablo; Soberino, Jesus; Alva, Manuel; Pascual, Tomas; Lema, Laura; Garcia-Fructuoso, Isabel; Cobos-Fernandez, Maria Angeles; Rey, Maria; Manso, Luis; Aguirre, Angela; Madariaga, Ainhoa; Sirenko, Valeria; Gonzalez-Deza, Cristina; Blasco, Paula; Mayhua, Astrid; Castillo, Oleguer; Galvan, Patricia; Sanfeliu, Esther; Villacampa, Guillermo; Buckingham, Wesley; Marin-Aguilera, Mercedes; Pare, Laia; Villagrasa, Patricia; Perou, Charles M.; Maues, Julia; Braso-Maristany, Fara; Ciruelos, Eva
Correlation of the HER2DX Genomic Test withPathologic Features in Early-Stage HER2+BreastCancer
LABORATORY INVESTIGATION
IF4.2
2025-03-010
PRE
Sanfeliu, Esther; Martinez-Romero, Anabel; Marin-Aguilera, Mercedes; Gonzalez-Farre, Blanca; Galvan, Patricia; Infantes, Angela Aguirre; Alarcon, Valeria Sirenko; Blasco, Paula; Castillo, Oleguer; Hernandez-Illan, Eva; Jares, Pedro; Puig-Butille, Joan Anton; Martinez, Antonio; Munoz, Montserrat; Losada, MariaVidal; Pascual, Tomas; Martinez, Olga; Solis, Elia Segui; Garcia-Fructuoso, Isabel; Cejalvo, Juan Miguel; Ciruelos, Eva; Brunet, Laia Pare; Vivancos, Ana; Villagrasa, Patricia; Buckingham, Wesley; Parker, Joel; Braso-Maristany, Fara; Prat, Aleix
Linking tumor immune infiltration to enhanced longevity in recurrence-free breast cancer
ESMO OPEN
IF8.3
2025-01-010
OAAI
Angelats, L.; Pare, L.; Rubio-Perez, C.; Sanfeliu, E.; Gonzalez, A.; Segui, E.; Villacampa, G.; Marin-Aguilera, M.; Pernas, S.; Conte, B.; Albarran-Fernandez, V.; Martinez-Saez, O.; Aguirre, A.; Galvan, P.; Fernandez-Martinez, A.; Cobo, S.; Rey, M.; Martinez-Romero, A.; Walbaum, B.; Schettini, F.; Vidal, M.; Buckingham, W.; Munoz, M.; Adamo, B.; Agrawal, Y.; Guedan, S.; Pascual, T.; Agudo, J.; Grzelak, M.; Borcherding, N.; Heyn, H.; Vivancos, A.; Parker, J. S.; Villagrasa, P.; Perou, C. M.; Prat, A.; Braso-Maristany, F.
Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in patients with HER2-positive early breast cancer (EBC)

HER2阳性早期乳腺癌（EBC）患者新辅助治疗期间残留病灶（RD）生物学及基因表达变化的预后价值

ANNALS OF ONCOLOGY
IF65.4
2024-12-010
PRE
Fernandez-Martinez, A.; Tanioka, M.; Ahn, S. G.; Zagami, P.; Pascual, T.; Rediti, M.; Tang, G.; Hoadley, K. A.; Venet, D.; Rashid, N. U.; Spears, P. A.; Llombart-Cussa, A.; Di Cosimo, S.; de Azambuja, E.; Choudhury, A.; Rastogi, P.; Islam, M. N.; Swain, S. M.; Cortes, J.; Sotiriou, C.; Prat, A.; Perou, C. M.; Carey, L. A.
Identifying predictors of treatment response and molecular changes induced by neoadjuvant chemotherapy and endocrine therapy in hormone receptorpositive/HER2-negative breast cancer: the NEOENDO translational study
ESMO OPEN
IF8.3
2024-12-011
PRE
Schettini, F.; Braso-Maristany, F.; Pascual, T.; Lorman-Carbo, N.; Nucera, S.; Bergamino, M.; Galvan, P.; Conte, B.; Segui, E.; Fructuoso, I. Garcia; Bravo, R. Gomez; Rodriguez, A. B.; Martinez-Saez, O.; Chic, N.; Vidal, M.; Adam, B.; Gonzalez-Farre, B.; Sanfeliu, E.; Cebrecos, I.; Mension, E.; Oses, G.; Locci, M.; Molla, M.; Ganau, S.; Jares, P.; Vidal-Sicart, S.; Munoz, M.; Prat, A.

研究方向

暂未获取到该数据
A
Aleix Prat
H 指数:92论文数:1,351被引数:3.6万
P
Patricia Galván
H 指数:37论文数:313被引数:6,533
M
María Vidal
H 指数:43论文数:425被引数:1.1万
L
Laia Paré
H 指数:43论文数:431被引数:7,294
M
Montserrat Muñoz-Mateu
H 指数:50论文数:620被引数:9,876
F
Fara Brasó‐Maristany
H 指数:28论文数:304被引数:3,781
P
Patricia Villagrasa
H 指数:28论文数:207被引数:3,478
B
Blanca González‐Farré
H 指数:34论文数:200被引数:5,257
M
Mafalda Oliveira
H 指数:48论文数:564被引数:1.3万
N
Núria Chic
H 指数:20论文数:149被引数:2,749